GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomaxima SA (WAR:BMX) » Definitions » Cyclically Adjusted Revenue per Share

Biomaxima (WAR:BMX) Cyclically Adjusted Revenue per Share : zł15.99 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biomaxima Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Biomaxima's adjusted revenue per share for the three months ended in Mar. 2024 was zł2.750. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is zł15.99 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Biomaxima's average Cyclically Adjusted Revenue Growth Rate was 2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-19), Biomaxima's current stock price is zł16.40. Biomaxima's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was zł15.99. Biomaxima's Cyclically Adjusted PS Ratio of today is 1.03.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Biomaxima was 4.55. The lowest was 0.77. And the median was 1.75.


Biomaxima Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Biomaxima's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomaxima Cyclically Adjusted Revenue per Share Chart

Biomaxima Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 10.39 14.82 15.84

Biomaxima Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.60 15.75 15.73 15.84 15.99

Competitive Comparison of Biomaxima's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, Biomaxima's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomaxima's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomaxima's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Biomaxima's Cyclically Adjusted PS Ratio falls into.



Biomaxima Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biomaxima's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.75/149.0435*149.0435
=2.750

Current CPI (Mar. 2024) = 149.0435.

Biomaxima Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.702 101.180 2.507
201409 1.536 100.611 2.275
201412 1.694 100.122 2.522
201503 1.729 100.041 2.576
201506 1.791 100.448 2.657
201509 1.727 99.634 2.583
201512 1.978 99.471 2.964
201603 1.923 98.983 2.896
201606 1.779 99.552 2.663
201609 1.622 99.064 2.440
201612 3.030 100.366 4.500
201703 2.091 101.018 3.085
201706 2.063 101.180 3.039
201709 2.161 101.343 3.178
201712 2.145 102.564 3.117
201803 2.025 102.564 2.943
201806 2.073 103.378 2.989
201809 1.946 103.378 2.806
201812 2.218 103.785 3.185
201903 2.000 104.274 2.859
201906 2.094 105.983 2.945
201909 1.805 105.983 2.538
201912 2.275 107.123 3.165
202003 1.808 109.076 2.470
202006 3.663 109.402 4.990
202009 3.253 109.320 4.435
202012 5.222 109.565 7.104
202103 5.955 112.658 7.878
202106 3.292 113.960 4.305
202109 3.247 115.588 4.187
202112 5.144 119.088 6.438
202203 21.009 125.031 25.044
202206 5.515 131.705 6.241
202209 2.936 135.531 3.229
202212 2.993 139.113 3.207
202303 2.537 145.950 2.591
202306 2.453 147.009 2.487
202309 2.868 146.113 2.926
202312 3.184 147.741 3.212
202403 2.750 149.044 2.750

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Biomaxima  (WAR:BMX) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Biomaxima's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=16.40/15.99
=1.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Biomaxima was 4.55. The lowest was 0.77. And the median was 1.75.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Biomaxima Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Biomaxima's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomaxima (WAR:BMX) Business Description

Industry
Traded in Other Exchanges
Address
5 Vetterow Street, Lublin, POL, 20-277
Biomaxima SA is a Polish company, produces microbiology media as well as a wide range of reagents and in Vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics companies such as Nova Biomedical, Mitsubishi Chemical and Biologist. Its products include Systems Antibiotic Susceptibility Testing, Urine Analysis Systems, Hematological Reagents along with Analyzers, ion Selective Analyzers with Reagents, Immunological Analyzer of Cardiac markers with reagents, Glucose Meters and analyzers for Gasometric and Critical Blood Tests.

Biomaxima (WAR:BMX) Headlines

No Headlines